Jeffrey Barnes, MS, MBA
Managing Director

Jeffrey Barnes, MS, MBA, joined BioVentures Investors in 2010 and is currently a Managing Director. He brings over 35 years of start-up, operating, and investment experience in the life sciences and healthcare sectors.

Prior to joining BioVentures Investors, Jeff was Managing Partner at Oxford Bioscience Partners, a venture fund. There, he was responsible for building and leading the firm's investment strategy in medical devices and diagnostic instrumentation, as well as originating and overseeing investments in 18 portfolio companies. Jeff was instrumental in the successful acquisition of seven medical device companies by strategic acquirers, including Edwards Lifesciences, Medtronic, ThermoFisher, Boston Scientific and Olympus Corp. Prior to venture capital, Jeff spent eight years in investment banking within the healthcare groups of Needham & Co. and Robertson, Stephens & Co.

Previously, Jeff had over 12 years of operating experience in the medical products field, including eight years in management positions in research and development, manufacturing, and marketing within the Medical Products Group of Hewlett-Packard Corp. He has served on the Board of Directors of more than 20 public and private healthcare technology companies, and he holds patents in diagnostic imaging technology and physiological signal processing. In addition, Jeff has been a co-founder of numerous medical device start-ups, including Mitralign, Circulite, Accelerated Technologies, Percutaneous Valve Technologies, Applied Spine Technologies, and Claros Diagnostics.

Jeff is a member of the Clinical Cardiology Council of the American Heart Association, the National Society of Professional Engineers, and the Association for the Advancement of Medical Instrumentation. He is also on the Board of Advisors at the Duke University Center for Entrepreneurship and Innovation. Jeff is currently a member of the Board of Directors for Deep Vein Medical, CoNextions and Rachiotek.

Jeff holds a BS degree in Physiology and Biophysics and an MS degree in Biomedical Engineering from Duke University, and an MBA degree in Management from Stanford University.